KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Accured Expenses (2016 - 2026)

AbbVie has reported Change in Accured Expenses over the past 14 years, most recently at -$598.0 million for Q4 2025.

  • Quarterly Change in Accured Expenses fell 147.96% to -$598.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $951.0 million through Dec 2025, up 437.29% year-over-year, with the annual reading at $951.0 million for FY2025, 437.29% up from the prior year.
  • Change in Accured Expenses was -$598.0 million for Q4 2025 at AbbVie, down from $1.7 billion in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.5 billion in Q3 2023 and troughed at -$1.7 billion in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $266.0 million (2021), against an average of $422.8 million.
  • Year-over-year, Change in Accured Expenses plummeted 363.89% in 2022 and then soared 928.42% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $265.0 million in 2021, then skyrocketed by 382.26% to $1.3 billion in 2022, then crashed by 85.99% to $179.0 million in 2023, then soared by 596.65% to $1.2 billion in 2024, then tumbled by 147.96% to -$598.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Change in Accured Expenses are -$598.0 million (Q4 2025), $1.7 billion (Q3 2025), and $515.0 million (Q2 2025).